Because ROS are also implicated in Notch3 signaling pathway [42], [43], we tested the hypothesis that MSeA could repress the desensitization of OVCA429/NICD3 ovarian cancer cells to carboplatin. The gene discussed is NOTCH3; the disease is ovarian carcinoma.